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Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which led to a worldwide pandemic that started in
early 2020. Healthcare systems across the world encountered an unprecedented
surge of COVID-19 patients resulting in more than half a million deaths globally.
COVID-19 has affected multiple sub-specialties and procedure-related fields, including
gastroenterology. Gastrointestinal (GI) endoscopy centers are specialized units where
thousands of endoscopies are performed annually. A significant proportion of these
procedures are affected due to the national and regional lockdowns across the globe. To
adapt to this rapidly evolving situation, endoscopy centers have undergone significant
changes and have taken unprecedented precautions to avoid the transmission of the
virus. However, endoscopy centers are going through financial strain due to a reduction
in the number of procedures from lockdowns and fear of virus transmission. Theoretically,
endoscopies could add to the disease transmission as SARS-CoV-2 has shown to
be present in the GI secretions. Multiple precautions such as mandatory use of face
masks, safe distancing, use of barriers between the endoscopists and patients, negative
pressure rooms, extended use of personal protective equipment, and volume reduction
have been taken to decrease the risk of disease transmission by these centers. Moreover,
pre-endoscopy COVID-19 testing has now become the norm. In this review, we highlight
the significant changes assumed by the endoscopy center. Furthermore, we discuss
cost-related concerns of pre-endoscopy COVID-19 testing, the downtime and delays
related to the procedures, and effects of rescheduling. As the pandemic progresses
through multiple phases, endoscopy centers should use a dynamic approach to adapt
and strive to provide the best patient care.
Keywords: coronavirus, coronavirus (2019-nCoV), SARS-CoV-2 infection, pandemic (COVID-19), endoscopy,
gastrointestinal disease, fellowship and training
INTRODUCTION
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2). Within a few months, it has led to a pandemic of unprecedented
levels affecting multiple countries with >16 million cases and >650,000 deaths as of July 26,
2020 (1). The pandemic has caused duress for medical systems and hospitals worldwide. Initially,
it was believed that respiratory manifestations dominate the presentation of COVID-19. As the
experience with the pandemic evolved, extrapulmonary manifestations are increasingly being
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recognized (2–6). The Centers for Disease Control and
Prevention (CDC) added multiple symptoms as a part of the
COVID-19 presentation, which also includes gastrointestinal
(GI) manifestations such as nausea, vomiting, dysgeusia,
pancreatitis, hepatitis, colitis, etc. (6–10). Additionally, the virus
has also been shown to be present in GI secretions. Specialties
such as gastroenterology and surgery have been directly affected
by COVID-19. This pandemic has had a disruptive effect on
the workflow and safety of endoscopists, ancillary staff, and
patients. Shortages of personal protective equipment (PPE), lack
of testing kits, reduced patient volume, workforce furloughs, and
lockdowns have forced these units to be innovative and have
them prioritize the high-risk procedures and postpone or even
cancel endoscopies in medium- to low-risk cases (11).
Outpatient endoscopy centers usually deal with high-volume
and close-contact procedures, which could make them prone
to become high-risk COVID-19 transmission areas if extreme
precautions are not taken. Millions of colonoscopies are
performed as part of the colorectal cancer screening program
in the United States (US) (12, 13). A wide variety of other
therapeutic endoscopic procedures are also performed on a
regular basis (14). Furthermore, the staging and palliation of
cancers to aid in managing these lesions are increasingly being
performed (15). The COVID-19 pandemic has forced these
endoscopy centers to drastically reduce the procedure volume for
both elective and semi-urgent cases to reduce transmission risk
and preserve PPE (16–19).
Furthermore, there are published data about a decrease in the
non-variceal GI bleeding events in line with other disorders such
as acute coronary syndrome admissions during the pandemic
(20). Although the precise reason for these changes remains
speculative, patients may have developed a fear of contracting
the infection if they visit the medical centers. Additionally, there
is an increased risk of exposure to the virus during outpatient
endoscopy procedures due to exposure to GI secretions and
respiratory secretions (21, 22). Furthermore, there is a potential
for increased generation of infected droplets during coughing,
retching, and suctioning, creating aerosolization and increased
risk of transmission (23, 24).
METHODS
A search for published literature at the time of submission
of the manuscript was performed from December 2019 to
July 1, 2020. We performed a search of PubMed, Google
Scholar, Embase, and Scopus databases to extract articles
relevant to endoscopy in COVID-19 patients. The terms
“endoscopy,” “gastrointestinal endoscopy,” “staffing,” “barrier
protection,” pre-procedure testing,” “COVID-19,” “SARS-CoV-2,”
and “coronavirus” were performed. Due to the heterogeneity of
the studies, a systemic review could not be performed.
CHANGES IN THE ENDOSCOPY SUITES
Changes in Endoscopy Suite Structure
Various operational changes have been proposed across
endoscopy suits/centers to provide services while mitigating the
risk of infection. While these changes depend on several factors
(availability of resources locally, infection risk, the demographic
profile of the patients, indication and hospital/ endoscopy unit
policies), common goals of minimizing the risk of transmission of
infection, conserving PPE, and achieving high efficiency remain.
To achieve these, Cennamo et al. reported substantial changes in
the layout of the endoscopy units with risk-based color-coding
of the waiting room, endoscopy suites, and recovery room (25).
Additionally, implementations of checkpoints, pathways, and
processes based on the color-coding schema were implemented
in this study (25). Post-procedure, patients are monitored in
the recovery area, with no family available in the waiting room.
Hospitals in the US have incorporated policies for not allowing
family members, given the risk of exposure and transmission
(26). Patients are transported to the hospital entrance to find
their respective family member/driver who can further assist
in discharge. Results of the procedures are discussed with the
patient but are relayed via phone to the authorized person with
face-to-face encounters (27). While these changes can potentially
contribute to the reduction of endoscopy-related transmission,
making it safer for the patients and the staff, they also decrease
the in-person relay of information, which is critical at the
discharge from the endoscopy units.
Changes in Staffing
COVID-19 first appeared in Wuhan, China, in December 2019.
In some areas, the pandemic has overwhelmed the healthcare
systems to the point that endoscopy units are potentially treated
as COVID-19 units (27, 28). In Brazil, endoscopy staff has
been divided into COVID treatment teams and non-COVID
endoscopy teams (27). The use of PPE has been mandated by
all healthcare systems to minimize the risk of transmission.
Prior studies have shown that the use of PPE has not been
universal among endoscopists (21, 23). However, with the current
pandemic, the use of masks, N-95, gowns, and other PPE
has drawn increased attention to avoid spread (24, 29, 30).
Endoscopy staff with pre-existing conditions at higher risk of
contracting COVID-19 have been assigned non-clinical duties
without direct care to COVID-19 patients (27, 28).
Endoscopy staff performing procedures in the operating
room should use strict precautions of properly donning and
doffing in a separate room prior to entering the operating
room. Endoscopy units and operating rooms should follow
strict cleaning procedures. Advanced endoscopy procedures
such as ERCP frequently need fluoroscopy, equipment trolley,
worktable, and anesthesia equipment. The negative pressure
rooms are highly recommended in these settings to avoid cross-
contamination.
Procedure scheduling during the peak and post-peak has
been an area of great challenge for hospitals (31). Increased
endoscopy staff furloughs further complicated this challenge (32).
Several patient procedures were deferred and put on hold due
to decreased slots and uncertainty about when the restrictions
will be lifted, and normalcy will be established. Post-procedure
telephone follow-ups with patients could be utilized to inquire
about developing any new COVID-19 related symptoms to take
necessary precautions to individuals who were at potential risk
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(24, 33). Patients should be informed about the risk of nosocomial
infections and also should be informed to report back if they
develop any de novo symptoms in the next few days after
the procedure.
Change in the Endoscopy Indications
Multiple international societies have recommended restricting
endoscopy procedures only to emergent and urgent indications
(34). This essential step was taken to minimize the risk of
transmission and reduce PPE utilization and use of resources.
Studies from multiple countries have shown an endoscopy case-
volume median reduction to as high as 99% (19, 35). The
impact of COVID-19 varied based on the country, infection rate,
initiation of stay-at-home orders, and timing of the pandemic.
For example, endoscopy services in the United Kingdom (UK)
reduced to 5% in March 2020 after the onset of the pandemic.
These changes were noted across all UK regions and endoscopy
procedures (36). Procedures were performed only when the
benefit outweighs the risk of transmission among the staff.
While the indication for procedures varied, emergent
procedures such as active GI bleeding, acute cholangitis,
food impactions, and cancer diagnosis/staging/treatment were
considered appropriate. A nationwide study in the UK showed
that all endoscopic procedures reduced with the pandemic;
however, the ERCP activity (performed for emergencies) remains
well-preserved (36). Elective procedures, such as screening and
surveillance, were deferred. However, the urgent indications
of endoscopies remain a gray area based on the endoscopist,
institutional guidelines, and available services. Deferring semi-
urgent cases could delay the diagnosis of cancers (such as
localized pancreatic cancer), and loss of window of therapeutic
intervention (endoscopically resectable lesions can become
unresectable due to spread). Studies showed that colorectal
cancer (CRC) screening declined by 84.5% after the onset of
the pandemic in the US (37). Similarly, a 72% reduction in
CRC screening was noted in the UK (36). Although multiple
GI societies have provided a road map, clinical judgment
should prevail, and every case should be individualized with a
multidisciplinary team-based approach (38).
Changes in Triaging
Endoscopy staff triage all patients who are undergoing non-
urgent endoscopies. In the US, this triaging is done by
the pre-procedural COVID-19 testing and a predetermined
questionnaire about 2–3 days before the endoscopy date (39, 40).
These patients are again triaged by this questionnaire at the time
of presentation to the endoscopy suite. The patients are sent to
the hospital to seek emergent medical attention in case they have
any signs and symptoms of COVID-19 such as cough, shortness
of breath, and persistent fever, along with a known history of
contact with a COVID-19 patient or travel to high-risk areas
(24, 41). Peri-procedural COVID testing involves coordination
at multiple levels—contacting patients to undergo testing 24 to
72 h before the procedure and obtaining the results of the test
(42). Patients who travel a long distance to get their procedure
may cancel their procedure if their COVID-19 testing results are
TABLE 1 | Pre-procedural universal testing.
Advantages Disadvantages
Results can assist in planning the
procedure based on risk and benefit
analysis
Significant cost burden
Use of PPE accordingly to negative or
positive cases
Risk of false-positives and
false-negatives
Planning of the procedure with enhanced
precautions and use of minimal personnel
(in positive cases) and adequate personnel
(in positive cases)
Delay in procedure during to
processing times
Decreased transmission risk, reduced
downtime and disinfection strategies
Additional trips to the
endoscopy center/ testing sites
delayed. Also, the absence of family members before, during, and
after the procedure can increase anxiety among the patients.
Pre-procedural Testing
COVID-19 testing of all patients before endoscopic procedures
may help to identify infected patients and facilitate taking
appropriate measures such as isolation precautions, high-risk
PPE usage for positive PCR testing, and downtime after the
procedure. A thorough analysis of the risks and benefits of
widespread pre-procedural testing is needed (Table 1). There
are some considerations needed before the development and
implementation of the universal testing strategy. Testing for all
patients incurs cost burden to the endoscopy units, which can
be significant. Additionally, testing may delay procedures if test
results are pending, and the possibility of false positivity and false
negativity might alter decision-making, which can complicate the
processes (1, 43).
Corral et al. reported that PCR testing could be used as
an effective strategy to restart endoscopic procedures based
on the phase of the pandemic (44). Testing individuals within
48 h of the procedure for semi-elective and elective cases can
allow completion of 19.4% (if investing $22 per patient) and
95.3% (if investing $105 per patient) of baseline endoscopies.
Implementing this strategy over 1 week in the US will return
165 million US dollars (for 13 million investing) and 767 million
US dollars (for 64 million investing) (44). These numbers are
promising and demonstrate the potential value of COVID-19
testing for all patients undergoing procedures. Expectedly, this
modeling can change with the local prevalence of COVID-19,
transmission rate (R0), and accuracy of PCR results. Center for
Medicaid and Medicare Services (CMS) and other insurance
programs reimburse up to 36 USD to 51 USD per patient (45).
These calculations may not apply in areas where testing is not
rampant, and reimbursement for endoscopy is low. For example,
Sundaram et al. noted that cost of SARS-CoV-2 PCR ($65)
might exceed the reimbursement of an upper endoscopy ($30–
$60) in countries like India (46). Additionally, the prevalence
rate in some of the areas of the country might be too low
to test all individuals undergoing endoscopy procedures (46).
Testing of high-risk individuals only in specific hot spots is
a matter of debate. Furthermore, pre-procedural testing is not
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uniformly performed in Europe, and the decision is based on
the pre-procedure questionnaire. As testing capabilities expand
throughout the world, the availability of highly accurate point-
of-care testing with rapid results can make this a possibility (47).
Barrier Protection
Safe distancing in the pre-operative area has decreased the
number of patients the nursing staff can receive for pre-operative
care. It has affected the efficiency of the endoscopy units severely.
Only required and critical personnel (endoscopists, nurses, and
anesthetists) should be allowed in the endoscopy units (42). Any
instrument or device can potentially be a source of infection in
aerosol-generating procedures (AGP). Staff should wear PPE as
per the local institutional and national guidelines before starting
the procedure. Appropriate donning and doffing of the PPE
is essential to reduce the risk of infection (27). Belle et al.
noted that gastroenterologists who performed procedures on
COVID-19 patients have reported symptoms compatible with
COVID-19 ranging from 0.6% (3/497 patients) in low prevalence
areas compared to 6.1% (12/197) in high prevalence areas (16).
Similarly, Chen et al. reported that 5.7% (8/141 patients) reported
that gastroenterologists or their colleagues developed work-
related COVID-19 infections (17). It led to the development of
multiple barrier devices between endoscopists and patients to
reduce the risk of exposure to GI secretions (48–53) (Table 2).
Given the inherent nature of the procedures (upper or
lower endoscopies), endoscopists are almost always in a “high-
transmission zone” (within 3 feet of the patients). Campos et al.
introduced a transparent aerosol box (endoprotector) to reduce
contact with droplets (49). In this technique, a barrier is used
during upper endoscopy, which is made of acrylic plastic to shield
the respiratory droplets and potential aerosolization during the
procedure (49). A similar barrier is used to decrease the exposure
to patients’ respiratory droplets during endotracheal intubation
(ETI) (50). Traina et al. reported the use of an endoscopic
COVID Cube (C-Cube), which is a protective box with access
to anesthesiologist’s hands and another port for endoscope
access (51). Liu et al. reported using a unique disposable device
with a combined bite block and oxygen mask for upper GI
endoscopic procedures (48). Furthermore, a closed chamber
ear, nose, and throat (ENT) examination unit was developed
for AGP endoscopic examinations of COVID-19 patients (54).
While ETI is usually a one-time event to secure the airway, the
use of an endoscope through an endoprotector might make the
procedure challenging due to the repeated hand movement of
the endoscopists. Nevertheless, the use of these barriers has a
significant role in reducing the disease transmission, especially
in high-risk or COVID-19 patients.
Endoscopic Transmission
Among the endoscopy procedures, duodenoscopes and
echoendoscopes carry a high risk of nosocomial infections
(55). While single-use duodenoscopes might be of value in
COVID-19-positive patients, they are not universally available
and have cost-related constraints (56). Multiple societies have
recommended using negative pressure rooms, especially for
patients who are suspected of COVID-19 or when the endoscopy
is being performed emergently without COVID-19 testing
results (30). Intraprocedural changes such as minimal verbal
communication, avoiding spill of GI contents via biopsy channel,
and avoiding procedures in patients with inadequate bowel
preparation should be done (27). Franzini et al. reported the use
of a “double gauze technique” where the endoscopists use one
gauze and the other by the technician in a controlled fashion
to avoid the “whip” effect of accessories and spillage of GI
secretions (27). Institutional policies have been developed for
minimal personnel to be present for the procedure (57). This
is to minimize the risk of exposure among the endoscopy staff.
Procedures performed with moderate sedation without the
need for anesthesia providers (endoscopist guided sedation)
can further minimize the risk of transmission. However, for
procedures requiring general anesthesia, societies currently
recommend using ETI to reduce the risk of aerosolization with
suspected or confirmed COVID-19 (58).
Enhanced cleaning procedures have been implemented by
most endoscopy units (24). Strict adherence to local and national
policies should be followed while cleaning the endoscopy suites
(59). This includes cleaning all horizontal surfaces, frequently
touched surfaces with particular emphasis on areas within a few
feet of the patient. Multiple studies showed that SARS-CoV-
2 can involve any segment of the GI tract. Intestinal autopsy
in COVID-19 patients showed stenosis and dilatation of the
small intestine (60). Mucosal damage was noted in multiple
areas such as esophagus, stomach, duodenum, colon, and rectum
(61, 62). Endoscopic procedures, due to their inherent nature
of coming in contact with GI secretions, could potentially get
contaminated with virus. Although there is a theoretical risk of
endoscopes acting as potential vectors for viral infections, so far,
there is no published report of SARS-CoV-2 transmission via
endoscopes (39). Nevertheless, the reprocessing process should
include high-level disinfection (HLD). Traditionally, testing for
leakage is performed before washing of the endoscope. However,
suggestions have beenmade for performing this after washing the
endoscope. Whether this can affect the proper functioning of the
scope remains to be studied (48).
Procedural Downtime
Patients undergoing endoscopy have the potential risk of aerosol
generation. All rooms after the procedure should be deemed
contaminated after the procedure. During the induction of
anesthesia, only essential personnel for securing the airway
should be present, which requires endoscopy staff to wait outside
the procedure room. After completing the endoscopic procedure,
the endoscopist and non-essential staff should exit the room
before extubating the patient.
The time needed to allow for dispersion of the virus-laden
aerosols to clear will depend on the rate of air changes/hour
(ACH). If a rate of 25–30 cycles/hour is used, 3min are needed
to wait before a procedure could be started after intubation. The
precise time needed for closure of the room depends on the use
of negative pressure and air-exchange rate (63). While this is
dependent on transmission dynamics, multiple other factors such
as air-exchange rate, duration of aerosolized droplets suspended
in the air, viral load in the droplets, the viability of the virus (can
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TABLE 2 | Barriers to prevent transmission during endoscopy.
Name Material Description
Endoprotector (40) Acrylic plastic Composed of four faces of the box. Face A (for endoscope insertion), B (for anesthetist), C
(air aspiration and creation of negative pressure), D (for patients’ neck and shoulders)
C-Cube (42) Plexiglas Multiple entryways (endoscopists and anesthesiologists’ access) for procedures involving oral
cavity
Aerosol box (41) Plastic Predominately used for endotracheal intubation. Two circular ports provided for the clinician
hands to perform airway procedure
ORIGAMI (43) Coated cardboard and
polypropylene film
Disposable face-protective shield to protect surgical mask and N-95 respiratory mask from
aerosols
Endoscopic shield (44) Plastic cube Two small holes for endoscopist access to the oral cavity
Chamber unit (45) Multiple structures For Ear, Nose, Throat exams- Composed of air inlet, ultraviolent lamps, exhaust system with
vents, speaker and additional screen






High viral load in the droplet
secretions (contaminant
concentration)
High air changes per hour (ACH)
Heavy environmental contamination Efficient vent system (removal
efficiency)
Air stagnation Negative pressure room
availability
Large room volume Good mixing of the air within the
space
*Final factors determining the downtime is dependent on transmission dynamics,
manufacturer recommendations and contaminant concentrations.
be up to 3 h), and environmental contamination could play a role
(Table 3).
A cautious approach is recommended until further data
emerge (19). Per the CDC (63), airborne contaminant removal
is dependent on ACH and duration, which determines the
efficiency of removal. For example, a roomwith aminimumACH
of 12–15 cycles per hour, at a duration of 28min to 35min, is
needed to achieve a contaminant removal efficiency of 99.9%
(63). This efficiency comes down if the ACH is low and if viral
contamination in the air is high. Societies have recommended
adequately ventilated rooms (with at least 12 ACH and controlled
direction of airflow with mechanical ventilation should be used).
For rooms without negative pressure capability, a minimum of
60min delay (downtime) is recommended compared to 30-min
downtime for negative pressure room (24).
Endoscopy Trainee Involvement
Endoscopy trainees’ (gastroenterology fellows and surgery
residents) involvement in GI procedures have been affected
significantly during the pandemic (64, 65). A multinational
survey study spanning 63 countries reported a reduction of
endoscopy volume by up to 93.8%, with colonoscopy being
affected the most, which is a core endoscopy skill (35).
Furthermore, an increased degree of anxiety and burnout were
noted among endoscopists. This concern not only was restricted
to trainees but also affected entire endoscopy staff for the risk of
acquiring COVID-19, especially after the resumption of elective
endoscopies (66). However, in areas with low risk of infection
transmission, trainees continue to be involved in the procedures.
During the initial phase of the pandemic, most endoscopy
units implemented policies to have only essential fully trained
staff to avoid exposure and reduce the turnover time (30).
Multiple survey studies have demonstrated adverse effects on
endoscopy training and an unexpectedly significant fear and
anxiety during pandemic (35, 67, 68). Multiple GI and surgical
societies have increased the availability of electronic resources
to fill this gap in the training (69, 70). Additionally, programs
have implemented various mechanisms to mitigate the loss of
procedure volume with video recording, simulation labs, and
increasing involvement in low-risk procedures.
FUTURE OUTLOOK OF ENDOSCOPY
UNITS
In the future, endoscopy units will likely incorporate some
of the changes during the pandemic for increased safety of
the patients and endoscopy staff. It remains speculative to
predict the end of this pandemic, but localized outbreaks may
continue to occur even when we see a pandemic downtrend
(71). Important questions remain open if endoscopy staff and
patients should continue to be screened and tested regularly. It
is only presumptive to say about the effect of cancer burden due
to delayed screening, surveillance, and handling the increased
backlog cases. Multiple strategies can be adopted to decrease
or ease endoscopy demand. Patients who are eligible for the
screening should be provided with options of CRC screening,
including stool-based testing, which do not need patients to
present to the healthcare facilities. Home-based stool testing has
the advantage of testing without contact with hospitals or clinics
(72). For patients who test positive, there is a significant risk of
advanced adenomas on the endoscopy, and hence a triage system
should be developed to prioritize the procedures (72). Because
of these, there will be increased demand in the recovery phase
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that likely needs to be phased appropriately to avoid significant
waiting times for procedures that need to happen in a timely
fashion. It involves careful evaluation of patient demographics
(comorbidities) and environmental factors (staff availability, local
resources, community spread, and infection rate) (73). As the
recovery phase starts, the real effect on the delay in cancer
screening will emerge.
Patients should be communicated about the importance of
screenings in the recovery phase to avoid delays and to keep
the appointments. There should be an effective use of electronic
health record communication strategies to provide updates to
patients about COVID-19-related changes in endoscopy units.
Virtual tools such as increased telehealth visits to discuss and
engage patients about cancer screening programs will increase
the endoscopy show rates (74). A triage system to review all the
posted case by qualified medical personnel and reschedule the
procedures in a tiered fashion can make this process less stressful
(42). Furthermore, endoscopy staff should communicate with
schedulers about the patient’s concerns, which can be directly
addressed. Finally, a higher threshold should be adopted for
endoscopy procedures, which will less likely change the outcomes
in patients (75). Despite these changes, as this pandemic unfolds
with localized outbreaks, endoscopy units remain at a threat
of temporary closures and need for enhanced disinfection
protocols. Preparing for future pandemics should be a part of the
operation of the endoscopy units’ stress response. Nevertheless,
endoscopy units should continue to adapt and navigate to
provide high-quality patient care with equal emphasis on patient
and staff safety.
LIMITATIONS
Due to the rapidly evolving nature of the COVID-19
pandemic, endoscopy units continue to adapt, and the above
recommendation can change. Due to the heterogeneity of the
published literature, we could not perform a systematic review.
Pre-procedural testing, triaging, and trainee involvement in the
procedures are dependent on infection risk, local endoscopy
unit, and hospital policies. As countries are starting the recovery
phase of the COVID-19 pandemic, these measures are constantly
being updated.
CONCLUSION
Endoscopy units are on the verge of significant changes and
evolution with the unfolding of the COVID-19 pandemic.
The current pandemic calls for multiple changes at different
levels not only to perform procedures in a safe environment
for patients but also to prevent infection to the endoscopy
staff. It appears likely that COVID-19 will be an integral
part of our lives, like other viruses such as influenza. Similar
to other procedures’ predominant specialties, endoscopy
units are incorporating operational changes in order to
provide care in these unprecedented times. The use of
enhanced protocols with particular emphasis on assessing
the risk status of the patient, proper use of PPE, and
perioperative procedural changes incorporated during
this pandemic should be a lesson for the future. While
some of these changes can gain permanent stance in the
future, adapting to the future outbreaks is critical to provide
excellent care.
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